What is FendX Technologies?
FendX Technologies is a pioneering nanotechnology firm dedicated to developing advanced products designed to make everyday life safer. The company's core mission revolves around reducing the spread of dangerous pathogens through cutting-edge material science and engineering. FendX possesses a robust and expanding intellectual property portfolio, featuring licensed nonprovisional national stage patent applications filed across key global markets including Canada, the United States, Europe, China, Hong Kong, and Japan. This extensive patent coverage highlights the company's commitment to innovation and its global market aspirations in the critical field of pathogen control.
How much funding has FendX Technologies raised?
FendX Technologies has raised a total of $511K across 3 funding rounds:
Private Equity
$100K
Private Equity
$357K
Private Equity
$54K
Private Equity (2025): $100K, investors not publicly disclosed
Private Equity (2025): $357K, investors not publicly disclosed
Private Equity (2026): $54K, investors not publicly disclosed
What's next for FendX Technologies?
With the recent influx of substantial expansion capital, FendX Technologies is poised for significant growth and market penetration. The enterprise-level investment suggests a strategic focus on scaling operations, accelerating product development, and broadening the commercialization of its nanotechnology-based safety solutions. This financing will likely enable FendX to further solidify its intellectual property position, expand its manufacturing capabilities, and establish key strategic partnerships to bring its pathogen-reducing technologies to a wider audience. The company's trajectory indicates a strong potential to become a leader in the nanotechnology safety sector.
See full FendX Technologies company page
